You just read:

Novartis heart failure treatment (Pr)Entresto™ (sacubitril/valsartan) now available to patients in Ontario through the public provincial drug plan

News provided by

Novartis Pharmaceuticals Canada Inc.

May 09, 2017, 05:59 ET